Enzymotec raises $61.8 million in IPO

Medical food company Enzymotec Ltd. (NASDAQ:ENZY) raised $61.8 million through the sale of 4.4 million shares at $14 in an IPO below its proposed price range. The price values the company at $292.4 million. Last week, Enzymotec amended the IPO to sell 4.4 million shares at $16-$18. At the $17 midpoint, the company would have raised $75 million and been valued at $355 million. In August, the company filed to raise up to $75 million in the offering. The first day of trading is slated for Friday. BofA Merrill Lynch; Jefferies; Wells Fargo; Canaccord; and Wedbush are underwriters. ...